Table 5.
Results of patient questionnaire n (%)
| Variable |
Overall |
Excluding patients with severe constipation |
P value |
|||
| A (mosapride) | B (placebo) | C (mosapride) | D (placebo) | A vs B | C vs D | |
| No. of patients | 124 | 125 | 108 | 120 | ||
| Compliance > 80% | 120 (96.8) | 119 (95.2) | 105 (97.2) | 114 (95.0) | NS | NS |
| 100% intake | 112 (90.3) | 115 (92.0) | 97 (89.8) | 110 (91.7) | NS | NS |
| Any symptom | ||||||
| Nausea | 5 (4.0) | 6 (4.8) | 3 (2.7) | 4 (3.3) | NS | NS |
| Vomiting | 0 | 1 (0.8) | 0 | 0 | NS | NS |
| Distension | 40 (32.3) | 31 (24.8) | 31 (28.7) | 28 (23.3) | NS | NS |
| Abdominal pain | 4 (3.2) | 2 (1.6) | 3 (2.8) | 2 (1.7) | NS | NS |
| Circulatory reactions | 0 | 0 | 0 | 0 | NS | NS |
| Willingness to repeat the same regimen | 77/115 (66.9) | 82/112 (73.2) | 67/100 (67.0) | 79/108 (73.1) | NS | NS |
| How easy/difficult to take preparation compared with previous one (easy/invariable/difficult) | 34/42/10 | 24/67/7 | 32/37/8 | 23/66/5 | < 0.05 | < 0.05 |
P value by the χ2 test. NS: Not significant.